
Quetiapine Fumarate
150 mg/1 · Extended-Release Tablet
By Novast Laboratories, Ltd.
Extended-Release Tablet · 150 mg
- NDC
- 34908-636
- Route
- Oral
- Therapeutic class
- Atypical Antipsychotic
- Marketing category
- ANDA
Package sizes
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-636-30)NDC 34908-636-30Available to Order
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-636-60)NDC 34908-636-60Available to Order
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-636-90)NDC 34908-636-90Available to Order
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-636-10)NDC 34908-636-10Available to Order
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a quote
Request this medication.
Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Ophthalmic & Otic
See all →6% Hetastarch in 0.9% Sodium Chloride
6 g/100mL · Injection Solution
HF Acquisition Co LLC, DBA HealthFirst
Available to Source
Fng
Liquid
Deseret Biologicals, Inc.
Available to Source

Bact Combination
Liquid
Deseret Biologicals, Inc.
Available to Source

Bact Combination
Liquid
Deseret Biologicals, Inc.
Available to Source
